View Older Stories View More Recent Stories

Jul 18, 2025 06:20AM Rhythm Pharmaceuticals (RYTM) PT Raised to $105 at Canaccord Genuity

Jul 15, 2025 06:06AM Rhythm Pharmaceuticals (RYTM) PT Raised to $109 at BofA Securities

Jul 14, 2025 05:23AM Citizens JMP Upgrades Rhythm Pharmaceuticals (RYTM) to Market Outperform

Jul 10, 2025 07:42AM Morgan Stanley Reiterates Overweight Rating on Rhythm Pharmaceuticals (RYTM)

Jul 10, 2025 06:25AM Goldman Sachs Resumes Rhythm Pharmaceuticals (RYTM) at Buy

Jul 10, 2025 06:22AM Rhythm Pharmaceuticals prices $175 million stock offering at $85 per share

Jul 10, 2025 06:16AM Rhythm Pharmaceuticals (RYTM) PT Raised to $110 at Oppenheimer

Jul 9, 2025 04:18PM Rhythm Pharmaceuticals (RYTM) PT Raised to $102 at Leerink Partners

Jul 9, 2025 04:16PM Rhythm Pharmaceuticals announces $150 million stock offering

Jul 9, 2025 12:47PM Rhythm Pharmaceuticals (RYTM) PT Raised to $123 at Stifel

Jul 9, 2025 12:45PM Rhythm Pharmaceuticals (RYTM) PT Raised to $95 at BofA Securities

Jul 9, 2025 09:15AM Stifel on Rhythm Pharmaceuticals (RYTM): 'Bivamelagon Data Look Very Solid and Meet/Exceed Our Bar'

Jul 9, 2025 08:00AM Rhythm Pharmaceuticals' bivamelagon shows BMI reduction in obesity trial

Jul 8, 2025 04:03PM Rhythm Pharmaceuticals to report phase 2 trial results for obesity drug

Jul 7, 2025 06:19AM Leerink Partners Starts Rhythm Pharmaceuticals (RYTM) at Outperform

Jul 2, 2025 04:07AM Citizens JMP Reiterates Market Outperform Rating on Rhythm Pharmaceuticals (RYTM)

Jun 26, 2025 04:08AM Citizens JMP Reiterates Market Outperform Rating on Rhythm Pharmaceuticals (RYTM)

Jun 5, 2025 05:24AM Jefferies Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)

Jun 5, 2025 04:25AM Citizens JMP Reiterates Market Outperform Rating on Rhythm Pharmaceuticals (RYTM)

May 29, 2025 08:36AM Rhythm Pharmaceuticals (RYTM) PT Raised to $94 at Stifel

May 14, 2025 08:03AM Rhythm Pharmaceuticals (RYTM) Announces New Data Presentations on Patients with Acquired or Congenital Hypothalamic Obesity (N=35) Treated with Setmelanotide for up to Nine Months

Apr 11, 2025 06:31AM Canaccord Genuity Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)

Apr 8, 2025 06:40AM Rhythm Pharmaceuticals (RYTM) PT Raised to $80 at H.C. Wainwright

Apr 8, 2025 06:37AM Rhythm Pharmaceuticals (RYTM) PT Raised to $92 at Canaccord Genuity

Apr 8, 2025 06:18AM Oppenheimer Reiterates Outperform Rating on Rhythm Pharmaceuticals (RYTM)

Apr 7, 2025 12:16PM BofA Securities Upgrades Rhythm Pharmaceuticals (RYTM) to Buy 'on valuation and lower risk'

Apr 7, 2025 07:27AM Stifel Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)

Apr 7, 2025 07:00AM Rhythm Pharmaceuticals (RYTM) Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction

Apr 1, 2025 06:17AM Wells Fargo Releases Regular Quarterly Update to Tactical Ideas List

Mar 27, 2025 04:35AM Citizens JMP Reiterates Market Outperform Rating on Rhythm Pharmaceuticals (RYTM)

Mar 24, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)

Mar 20, 2025 04:09PM Rhythm Pharmaceuticals (RYTM) Reacquires Licensing Rights to IMCIVREE in China with Termination of Agreement with RareStone Ltd.

Mar 19, 2025 04:01PM Rhythm Pharmaceuticals (RYTM) Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan

Mar 18, 2025 07:07AM Rhythm Pharmaceuticals (RYTM) PT Raised to $66 at Needham

Mar 11, 2025 09:01AM Stifel Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)

Mar 6, 2025 04:38AM Citizens JMP Reiterates Market Outperform Rating on Rhythm Pharmaceuticals (RYTM)

Mar 5, 2025 01:47PM Raymond James Reiterates Outperform Rating on Rhythm Pharmaceuticals (RYTM)

Mar 5, 2025 06:44AM Stifel Resumes Rhythm Pharmaceuticals (RYTM) at Buy

Mar 3, 2025 06:40AM Rhythm Pharmaceuticals (RYTM) PT Raised to $70 at H.C. Wainwright

Feb 28, 2025 07:58AM Rhythm Pharmaceuticals (RYTM) PT Raised to $94 at Guggenheim

Feb 27, 2025 06:54AM Rhythm Pharmaceuticals (RYTM) PT Raised to $81 at Canaccord Genuity

Feb 27, 2025 04:28AM Rhythm Pharmaceuticals (RYTM) PT Raised to $81 at Citizens JMP

Feb 26, 2025 07:14AM Rhythm Pharmaceuticals (RYTM) Tops Q4 EPS by 2c

Feb 4, 2025 05:01AM Rhythm Pharmaceuticals (RYTM) PT Maintained at $75 at JMP Securities

Dec 20, 2024 02:16PM Rhythm Pharmaceuticals (RYTM) Announces FDA Approval of IMCIVREE for Patients as Young as 2 Years Old

Dec 20, 2024 06:22AM Oppenheimer Starts Rhythm Pharmaceuticals (RYTM) at Outperform

Dec 19, 2024 09:42AM Stifel Names Top Picks in Biotechnology 2025 Outlook Note

Dec 5, 2024 05:43AM Rhythm Pharmaceuticals (RYTM) PT Raised to $66 at Goldman Sachs

Nov 25, 2024 06:44AM H.C. Wainwright Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)

Nov 6, 2024 09:05AM Rhythm Pharmaceuticals (RYTM) PT Raised to $65 at TD Cowen

View More Recent Stories View Older Stories